Regulation of the T cell response

The T cell branch of the immune system can respond to a virtually infinite variety of exogenous antigens, thus including the possibility of self‐antigen recognition and dangerous autoimmune reactions. Therefore, regulatory mechanisms operate both during ontogeny within the thymus and after birth in the periphery. The control of self‐reactive T cells occurs through a process of negative selection that results in apoptosis of T cells showing high affinity for self‐peptides expressed at the thymic level by means of promiscuous gene expression. Self‐reactive T cells escaped to negative selection are controlled in the periphery by other regulatory mechanisms, the most important being natural Foxp3+ T regulatory (Treg) cells. Regulation is also required to control excessive effector T cell responses against exogenous antigens, when they become dangerous for the body. Three types of effector T cells have been recognized: T helper 1 (Th1) cells, which are protective against intracellular bacteria; Th2 cells, which play some role in the protection against nematodes, but are responsible for allergic reactions; Th17 cells, which are probably effective in the protection against extracellular bacteria, but also play a role in the amplification of autoimmune disorders. Abnormal or excessive Th effector responses are regulated by different mechanisms. Redirection or immune deviation of Th1‐ or Th2‐dominated responses is provided by cytokines [interferon‐γ (IFN‐γ) vs. interleukin‐4 (IL‐4)] produced by the same cell types and by the CXCR3‐binding chemokines CXCL4 and CXCL10. Moreover, both Th1 and Th2 responses can be suppressed by adaptive Treg cells through contact‐dependent mechanisms and/or the production of IL‐10 and transforming growth factor‐β (TGF‐β). Finally, TGF‐β1 can promote the development of both Th17 effector and adaptive Treg cells, while the contemporaneous production of IL‐6 contributes to the development of Th17 cells, but inhibits Treg cells. The development of Th17 cells is also down‐regulated by IL‐4 produced by Th2 cells and by IFN‐γ produced by Th1 cells.

[1]  L. Fouser,et al.  Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides , 2006, The Journal of experimental medicine.

[2]  J. Powell The induction and maintenance of T cell anergy. , 2006, Clinical immunology.

[3]  L. Cosmi,et al.  Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release. , 2006, The Journal of allergy and clinical immunology.

[4]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[5]  C. Tato,et al.  Immunology: What does it mean to be just 17? , 2006, Nature.

[6]  Y. Iwakura,et al.  The IL-23/IL-17 axis in inflammation. , 2006, The Journal of clinical investigation.

[7]  Niamh E Mangan,et al.  Identification of an interleukin (IL)-25–dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion , 2006, The Journal of experimental medicine.

[8]  M. D’Elios,et al.  The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. , 2006, The Journal of clinical investigation.

[9]  R. Pelanda,et al.  Receptor editing for better or for worse. , 2006, Current opinion in immunology.

[10]  H. Bobby Gaspar,et al.  Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype , 2006, British journal of haematology.

[11]  C. Dong Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells , 2006, Nature Reviews Immunology.

[12]  S. Ziegler FOXP3: of mice and men. , 2006, Annual review of immunology.

[13]  Michael Loran Dustin,et al.  Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo , 2006, The Journal of experimental medicine.

[14]  P. Krammer,et al.  Death receptor signaling and its function in the immune system. , 2006, Current directions in autoimmunity.

[15]  A. Enk DCs and cytokines cooperate for the induction of tregs. , 2006, Ernst Schering Research Foundation workshop.

[16]  S. Sudowe,et al.  Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells. , 2006, The Journal of allergy and clinical immunology.

[17]  M. Rotondi,et al.  CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production. , 2005, The Journal of allergy and clinical immunology.

[18]  J. Bluestone,et al.  How do CD4+CD25+ regulatory T cells control autoimmunity? , 2005, Current opinion in immunology.

[19]  S. Ziegler,et al.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. , 2005, The Journal of clinical investigation.

[20]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[21]  S. Mazmanian,et al.  An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System , 2005, Cell.

[22]  G. Ruthel,et al.  Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[24]  P. De Baetselier,et al.  Lipoprotein I, a TLR2/4 Ligand Modulates Th2-Driven Allergic Immune Responses , 2005, The Journal of Immunology.

[25]  L. Peltonen,et al.  Autoimmune polyendocrinopathy syndrome type 1 (APS1) and AIRE gene: new views on molecular basis of autoimmunity. , 2005, Journal of autoimmunity.

[26]  Maureen A Su,et al.  Aire: an update. , 2004, Current opinion in immunology.

[27]  M. Kronenberg,et al.  Going both ways: immune regulation via CD1d-dependent NKT cells. , 2004, The Journal of clinical investigation.

[28]  J. Bluestone,et al.  Distinct roles of CTLA‐4 and TGF‐β in CD4+CD25+ regulatory T cell function , 2004 .

[29]  L. Chess,et al.  An integrated view of suppressor T cell subsets in immunoregulation. , 2004, The Journal of clinical investigation.

[30]  M. Claesson,et al.  CD4+CD25+ regulatory T cells: I. Phenotype and physiology , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[31]  A. Lindén,et al.  Interleukin-17 family members and inflammation. , 2004, Immunity.

[32]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[33]  B. Kyewski,et al.  Self-representation in the thymus: an extended view , 2004, Nature Reviews Immunology.

[34]  F. Simons,et al.  Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. , 2004, The Journal of allergy and clinical immunology.

[35]  P. Lipsky,et al.  Generation and Regulation of Human Th1-Biased Immune Responses In Vivo: A Critical Role for IL-4 and IL-10 1 , 2004, The Journal of Immunology.

[36]  B. Stockinger,et al.  IL-10-Secreting Regulatory T Cells Do Not Express Foxp3 but Have Comparable Regulatory Function to Naturally Occurring CD4+CD25+ Regulatory T Cells 1 , 2004, The Journal of Immunology.

[37]  Richard A Flavell,et al.  Instruction of Distinct CD4 T Helper Cell Fates by Different Notch Ligands on Antigen-Presenting Cells , 2004, Cell.

[38]  S. Zheng,et al.  Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity: The Role of IL-2, TGF-β, and IL-101 , 2004, The Journal of Immunology.

[39]  Peter R. Galle,et al.  Cutting Edge: TGF-β Induces a Regulatory Phenotype in CD4+CD25− T Cells through Foxp3 Induction and Down-Regulation of Smad7 , 2004, The Journal of Immunology.

[40]  D. Klinman Immunotherapeutic uses of CpG oligodeoxynucleotides , 2004, Nature Reviews Immunology.

[41]  R. Flavell,et al.  TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Bluestone,et al.  Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. , 2004, European journal of immunology.

[43]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[44]  T. Mcclanahan,et al.  Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.

[45]  S. Nakae,et al.  Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice 1 , 2003, The Journal of Immunology.

[46]  S. Szabo,et al.  Molecular mechanisms regulating Th1 immune responses. , 2003, Annual review of immunology.

[47]  Timothy K Starr,et al.  Positive and negative selection of T cells. , 2003, Annual review of immunology.

[48]  S. Ziegler,et al.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. , 2003, The Journal of clinical investigation.

[49]  Sergio Romagnani,et al.  An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4 , 2003, The Journal of experimental medicine.

[50]  T. Moseley,et al.  Interleukin-17 family and IL-17 receptors. , 2003, Cytokine & growth factor reviews.

[51]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[52]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[53]  L. Cosmi,et al.  The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells. , 2003, The Journal of allergy and clinical immunology.

[54]  M. Mack,et al.  Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease , 2003, Nature Medicine.

[55]  A. Mercenier,et al.  Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. , 2002, The Journal of allergy and clinical immunology.

[56]  L. Cosmi,et al.  Phenotype, Localization, and Mechanism of Suppression of CD4+CD25+ Human Thymocytes , 2002, The Journal of experimental medicine.

[57]  M. Ernst,et al.  Platelet Factor 4 Inhibits Proliferation and Cytokine Release of Activated Human T Cells1 , 2002, The Journal of Immunology.

[58]  A. Gurney,et al.  IL‐17: prototype member of an emerging cytokine family , 2002, Journal of leukocyte biology.

[59]  L. Cosmi,et al.  Reversal of human allergen-specific CRTH2+ T(H)2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide. , 2001, The Journal of allergy and clinical immunology.

[60]  W. Strober,et al.  Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β , 2001, The Journal of experimental medicine.

[61]  J. Shellito,et al.  Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.

[62]  M. Roncarolo,et al.  Type 1 T regulatory cells , 2001, Immunological reviews.

[63]  H. Weiner,et al.  Induction and mechanism of action of transforming growth factor‐β‐secreting Th3 regulatory cells , 2001, Immunological reviews.

[64]  E Lazzeri,et al.  Chemokines and lymphopoiesis in human thymus. , 2001, Trends in immunology.

[65]  H. Smits,et al.  IL‐12‐induced reversal of human Th2 cells is accompanied by full restoration of IL‐12 responsiveness and loss of GATA‐3 expression , 2001, European journal of immunology.

[66]  H. Asnagli,et al.  Stability and commitment in T helper cell development. , 2001, Current opinion in immunology.

[67]  J. Egen,et al.  CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. , 2001, Annual review of immunology.

[68]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.

[69]  D. Galas,et al.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.

[70]  Fiona Powrie,et al.  Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.

[71]  E. Raz,et al.  Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. , 2000, The Journal of allergy and clinical immunology.

[72]  S. Sakaguchi Regulatory T cells , 2000, Cell.

[73]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[74]  F. Annunziato,et al.  Phosphorothioate oligodeoxynucleotides promote the in vitro development of human allergen-specific CD4+ T cells into Th1 effectors. , 1999, Journal of immunology.

[75]  U. Andersson,et al.  Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. , 1999, Atherosclerosis.

[76]  V. Gangur,et al.  Human Ip-10 Selectively Promotes Dominance of Polyclonally Activated and Environmental Antigen- Driven Ifn-g over Il-4 Responses Human Ip-10 Selectively Promotes Dominance of Polyclonally Activated and Environmental Antigen- Driven Ifn-g over Il-4 Responses. Faseb , 2022 .

[77]  J. Holloway,et al.  Infection of Mice with Mycobacterium bovis–Bacillus Calmette-Guérin (BCG) Suppresses Allergen-induced Airway Eosinophilia , 1998, The Journal of experimental medicine.

[78]  S. Romagnani,et al.  The Th1/Th2 paradigm. , 1997, Immunology today.

[79]  W. Karpus,et al.  Differential CC chemokine-induced enhancement of T helper cell cytokine production. , 1997, Journal of immunology.

[80]  S. Park,et al.  Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.

[81]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[82]  M. Wills-Karp,et al.  Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. , 1996, Journal of immunology.

[83]  E. Gelfand,et al.  Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. , 1996, Journal of immunology.

[84]  G. Trinchieri,et al.  Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. , 1996, Journal of immunology.

[85]  R. Pauwels,et al.  Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. , 1996, American journal of respiratory and critical care medicine.

[86]  F. Annunziato,et al.  Polyinosinic acid: polycytidylic acid promotes T helper type 1‐specific immune responses by stimulating macrophage production of interferon‐α and interleukin‐12 , 1995, European journal of immunology.

[87]  S. Romagnani Lymphokine production by human T cells in disease states. , 1994, Annual review of immunology.

[88]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[89]  G. Trinchieri,et al.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.

[90]  M. de Carli,et al.  IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. , 1992, Journal of immunology.

[91]  M. de Carli,et al.  Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. , 1992, Journal of immunology.

[92]  S. Romagnani Human TH1 and TH2 subsets: doubt no more. , 1991, Immunology today.

[93]  A. Abbas,et al.  Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution , 1990, Infection and immunity.

[94]  W. Paul,et al.  Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4- producing cells , 1990, The Journal of experimental medicine.

[95]  R. Coffman,et al.  Heterogeneity of cytokine secretion patterns and functions of helper T cells. , 1989, Advances in immunology.

[96]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[97]  D. Green,et al.  Immunoregulatory T-cell pathways. , 1983, Annual review of immunology.

[98]  S. Liebhaber,et al.  Suppressor T cells. , 1972, Journal of immunology.